KRX AESTHETICS PD-13 THERAPY spray

KRX Aesthetics PD-13 Therapy by

Drug Labeling and Warnings

KRX Aesthetics PD-13 Therapy by is a Otc medication manufactured, distributed, or labeled by KRX RESOURCES SDN. BHD.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DOSAGE & ADMINISTRATION

How to use Krx Aesthetics PD-13 Therapy

1. Cleanse and exfoliate the skin. 2. Extraction of blackheads and whiteheads if necessary. 3. Apply Krx Aesthetics PDT 13% treatment and cover the skin. 4. Make sure the skin is fully covered / not exposed to light for 30 minutes. 5. Remove excess product on skin by wiping with sponge. 6. Use RED LED light for 20 minutes. Cover eyes. 7. Neutralize with Krx Aesthetics P DT Neutralizer. 8. Apply mask and repair cream. 9. Use sunblock.

WARNINGS

1. Keep out of reach of children 2. If irritation occurs, consult your dermatologist and stop usage. Please, check how to use the product and the precautions before you use it.

INACTIVE INGREDIENT

Glycerin, Propylene Glycol, Methyl Ami nolevulinate HCl, 1, 2- Hexanediol, Alcohol, Sodium Lactate, Water, Pentylene Glycol, Dipropylene Glycol

INDICATIONS & USAGE

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

PURPOSE

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

ACTIVE INGREDIENT

Methyl Aminolevulinate HCI 13%

PRINCIPAL DISPLAY PANEL

Package Labeling

INGREDIENTS AND APPEARANCE

KRX AESTHETICS PD-13 THERAPY 
krx aesthetics pd-13 therapy spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84755-0010
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
METHYL AMINOLEVULINATE HYDROCHLORIDE (UNII: 7S73606O1A) (METHYL AMINOLEVULINATE - UNII:585NM85KYM)	METHYL AMINOLEVULINATE	1.95 mg  in 15 mL

Inactive Ingredients
Ingredient Name	Strength
DIPROPYLENE GLYCOL (UNII: E107L85C40)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
GLYCERIN (UNII: PDC6A3C0OX)
PROPYLENE GLYCOL DICAPRYLATE/DICAPRATE (UNII: O4446S9CRA)
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
ALCOHOL (UNII: 3K9958V90M)
WATER (UNII: 059QF0KO0R)
SODIUM LACTATE (UNII: TU7HW0W0QT)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84755-0010-1	15 mL in 1 PACKAGE; Type 0: Not a Combination Product	01/01/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/01/2026

Labeler - KRX RESOURCES SDN. BHD. (813058498)

Registrant - KRX RESOURCES SDN. BHD. (813058498)

Establishment
Name	Address	ID/FEI	Business Operations
KRX RESOURCES SDN. BHD.		813058498	manufacture(84755-0010)